Censo Biotechnologies Ltd
Private Limited Company · Midlothian
ActiveUnited KingdomIncorporated 2008Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
SC348293- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2008-09-09
- Jurisdiction
- —
- Registered office
- 3ROSLIN INNOVATION CENTRE, CHARNOCK BRADLEY BUILDING, MIDLOTHIAN, EH25 9RG, SCOTLAND
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
4 SH01-derived rounds2025-12-24
£541,232 raised
£13,569,143 estimated post-money
2024-06-13
£3,762,286 raised
£16,555,145 estimated post-money
2023-10-11
£300,000 raised
£21,707,340 estimated post-money
2022-03-31
£3,206,763 raised
£28,341,537 estimated post-money
Research and innovation
6 matched grantsCenso Alveolar Macrophage for COPDLead
Innovate UK · Feasibility Studies · 2018-11-01 – 2019-07-31
£69,242
awarded
Development of pluripotent cell lines from Livestock, and animal models for pharmacology/toxicology applicationsBBSRC · Studentship · 2017-09-30 – 2022-05-29 · with 1 other participant£0whole project
Development of pluripotent cell lines from Livestock, and animal models for pharmacology/toxicology applications
BBSRC · Studentship · 2017-09-30 – 2022-05-29 · with 1 other participant
£0
whole project
University Of EdinburghleadCenso Biotechnologies Ltd
Patient Derived iPSCs for High Grade Glioma (PDi:HGG)LeadInnovate UK · Collaborative R&D · 2017-06-01 – 2019-05-31 · with 1 other participant£700,330awarded
Patient Derived iPSCs for High Grade Glioma (PDi:HGG)Lead
Innovate UK · Collaborative R&D · 2017-06-01 – 2019-05-31 · with 1 other participant
£700,330
awarded
Censo Biotechnologies Ltdlead£700,330
Use of a Novel Cell Printer to Create, Analyse and Optimise 3D Liver TissuesLead
Innovate UK · Feasibility Studies · 2013-07-01 – 2014-06-30
£117,432
awarded
Cell labelling for in vivo use and in process quality controlInnovate UK · Collaborative R&D · 2012-02-01 – 2015-09-30 · with 3 other participants£52,436awarded
Cell labelling for in vivo use and in process quality control
Innovate UK · Collaborative R&D · 2012-02-01 – 2015-09-30 · with 3 other participants
£52,436
awarded
Roslin Cellab£52,436
University of Edinburgh£0
Next generation cardiotoxicity assay platform using cardiomyocytesLeadInnovate UK · Collaborative R&D · with 1 other participant
Next generation cardiotoxicity assay platform using cardiomyocytesLead
Innovate UK · Collaborative R&D · with 1 other participant
Censo Biotechnologies Ltdlead—